NEUROLOGICAL DISORDER DRUGS MARKET ANALYSIS

Neurological Disorder Drugs Market, by Drug Type (Antipsychotic, Antiepileptic, Anticholinergic, Analgesics, Hypnotic & Sedative, Anticoagulants, and Antihypertensive), by Disease Type (Epilepsy, Parkinson’s Disease, Alzheimer’s Disease, Cerebrovascular Disease, Multiple Sclerosis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI2363
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Neurological Disorder Drugs Market: Key Players

Key players operating in the global neurological disorder drugs market include Amgen Inc., UCB S.A., Neurocrine Biosciences, Inc., Pfizer Inc., Biogen Inc., Teva Pharmaceutical Industries Ltd., AcelRx Pharmaceuticals, Inc., Eli Lilly and Company, Ionis Pharmaceuticals, Inc., Adamas Pharmaceuticals, Inc., BioMarin Pharmaceutical Inc., Otsuka America Pharmaceutical, Inc., AstraZeneca plc, and Novartis International AG.